XML 38 R25.htm IDEA: XBRL DOCUMENT
v3.25.4

Accrued Expenses and Other Current Liabilities (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2025
Accrued Liabilities, Current [Abstract] |
Schedule of Accrued Expenses and Other Current Liabilities | Accrued expenses and other current liabilities consisted of the following (in thousands):
|  | December 31, |
|  | 2025 |  |  | 2024 |
Accrued clinical and other research and development |  | $ | 30,235 |  |  | $ | 25,555 |
Accrued manufacturing |  |  | 10,976 |  |  |  | 11,511 |
Accrued employee compensation and benefits |  |  | 16,935 |  |  |  | 10,452 |
Accrued other and other current liabilities |  |  | 2,867 |  |  |  | 1,277 |
|  | $ | 61,013 |  |  | $ | 48,795 |

X
- Definition Tabular disclosure of the components of accrued liabilities and other current liabilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). + References No definition available. + Details
Name: | nuvl_ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock
Namespace Prefix: | nuvl_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_AccruedLiabilitiesCurrentAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration